RBC Raises Price Target on Apellis Pharmaceuticals to $26 From $24, Keeps Sector Perform Rating

MT NewswiresJan 7 20:56 · Ratings

Apellis Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 20:00

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS): When Will It Breakeven?

Simply Wall StDec 24, 2024 18:42

Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

BenzingaDec 17, 2024 21:04

This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

BenzingaDec 17, 2024 21:00

Apellis Pharmaceuticals Price Target Announced at $36.00/Share by Goldman Sachs

Dow JonesDec 17, 2024 20:23 · Ratings